Martingale Asset Management »

Supernus Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 36k 28.94
2023-09-30 $1.3M 48k 27.57
2023-06-30 $1.4M 48k 30.06
2023-03-31 $1.7M 46k 36.23
2022-12-31 $1.6M 46k 35.67
2022-09-30 $1.7M 49k 33.87
2022-06-30 $1.3M 45k 28.94
2022-03-31 $1.4M 42k 32.33
2021-12-31 $1.3M 46k 29.17
2021-09-30 $238k 8.9k 26.74
2021-03-31 $582k 22k 26.19
2020-12-31 $1.1M 42k 25.17
2020-09-30 $1.2M 57k 20.85
2020-06-30 $777k 33k 23.75
2018-12-31 $486k 15k 33.24
2018-09-30 $711k 14k 50.39
2018-06-30 $929k 16k 59.85
2015-09-30 $220k 13k 17.04
2015-06-30 $220k 13k 17.04